View more in
Cancer

Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications

360dx.com
 2021-06-09

NEW YORK – Presentations at the American Society of Clinical Oncology's virtual annual meeting this week signal continued growth in commercial liquid biopsy tests for tracking minimal residual disease, as well as clinical applications emerging for these assays. Companies with competing products in the clinic are amassing more data for...

www.360dx.com

Comments / 0

Comments / 0